文献速递组学、生物样本库与精准医学流行病学与生物统计基础与转化研究

2型糖尿病相关慢性肾病的蛋白质中介:孟德尔随机化研究

Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study.
PubMed 文献 · PLoS Med · 2026-09-11

本研究利用大规模蛋白质组学与全基因组关联数据,通过两样本孟德尔随机化识别受2型糖尿病遗传易感性影响的循环蛋白,并评估其对肾功能指标的因果效应。研究发现INHBC等五种蛋白影响尿素氮、估算肾小球滤过率及慢性肾病风险,其中INHBC水平升高与估算肾小球滤过率降低和尿素氮升高相关,并介导了2型糖尿病与肾病诊断关联的1.3%。

要点

  • 2型糖尿病遗传易感性改变71种循环蛋白水平。
  • INHBC等5种蛋白因果影响肾功能指标与慢性肾病风险。
  • INHBC介导2型糖尿病与肾病诊断关联的1.3%。

核心结论

  • 2型糖尿病部分通过升高循环INHBC水平影响慢性肾病风险。

研究设计与样本

  • 两样本孟德尔随机化研究,使用deCODE蛋白质组GWAS(35,559人)和2型糖尿病GWAS(80,154例)识别受糖尿病遗传易感性影响的循环蛋白。
  • 利用顺式遗传变异代理蛋白因果效应,基于最多1,004,040名参与者的GWAS评估对尿素氮、估算肾小球滤过率和慢性肾病风险的影响。
  • 在UKB-PPP、Fenland、ARIC和EPIC-Norfolk四个蛋白质组GWAS中重复孟德尔随机化分析。
  • 在37,854名英国生物银行参与者中进行观察性分析,评估INHBC与肾病诊断的关联。

主要发现

  • 识别出71种循环蛋白水平受2型糖尿病遗传易感性影响。
  • INHBC、GNPTG、LPO、AGRN和CTSD五种蛋白共同影响尿素氮、估算肾小球滤过率和慢性肾病风险三个肾脏指标。
  • 孟德尔随机化分析估计较高的循环INHBC水平导致较低的估算肾小球滤过率和较高的尿素氮。
  • 四个额外蛋白质组GWAS数据集中效应方向一致。
  • 观察性分析中,循环INHBC水平升高与肾病诊断风险增加相关,并介导2型糖尿病与肾病诊断关联的1.3%(95%置信区间[0.85%, 1.9%])。

临床怎么用

  • 循环INHBC可作为2型糖尿病相关慢性肾病的潜在生物标志物和干预靶点。

局限性

  • 孟德尔随机化假设部分无法检验。
  • 研究基于独立人群而非糖尿病肾病患者,需在疾病特异性队列中进一步功能分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) occurs in 20-50% of the people living with Type 2 diabetes (T2D) and is the leading cause of kidney failure worldwide. The cause of CKD is not fully understood, and few interventions prevent CKD in individuals living with diabetes. Here, we use large-scale proteomics data to identify circulating proteins that mediate the relationship between T2D and kidney disorders. METHODS AND FINDINGS: First, we used two-sample mendelian randomization (MR) and identified 71 circulating proteins whose levels were altered by genetic predisposition to T2D based on circulating proteomic GWAS from deCODE with 35,559 individuals and T2D GWAS with 80,154 cases. Then, we used cis-genetic variants to proxy the causal effect of some of these T2D-influenced circulating proteins and found that, collectively, five proteins (INHBC, GNPTG, LPO, AGRN, and CTSD) affected three kidney traits (blood urea nitrogen [BUN], estimated glomerular filtration rate [eGFR] and CKD risk) based on GWAS with up to 1,004,040 participants. Notably, we found that higher levels of circulating INHBC protein were estimated to lead to a lower eGFR and higher BUN based on MR analyses. We then replicated this MR analysis with proteomic GWAS from four additional cohorts, namely, UKB-PPP, Fenland, ARIC, and EPIC-Norfolk. We observed a consistent direction of effect across all four proteomic GWAS datasets, supporting the robustness of our results against platform and cohort variation. In observational analyses, increased circulating INHBC levels were associated with increased hazard for kidney disease diagnosis in 37,854 UK Biobank participants. We estimated that circulating INHBC levels mediate 1.3% (95% confidence interval [0.85%, 1.9%]) of the association between T2D and kidney disease diagnosis. There are important limitations in this study. Firstly, although we observed limited evidence for violations to the MR assumptions, some are untestable. Secondly, our study was not based on individuals with diabetic kidney diseases, but rather independent population-based studies assessing diabetes and kidney function separately. Therefore, additional functional analyses in disease specific cohort are needed. CONCLUSIONS: Collectively, these findings suggest that T2D influences the risk of CKD, in part, through increased circulating INHBC levels.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Liang KYH, Zheng TM, Tan D, et al. Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study. PLoS Med. 2026. PMID: 42726788. doi:10.1371/journal.pmed.1004802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。